Journal article
Prevention of Relapse in Generalized Social Phobia: Results of a 24-Week Study in Responders to 20 Weeks of Sertraline Treatment
Abstract
The aim of this study was to evaluate the efficacy, tolerability, and effects on quality of life of sertraline, a selective serotonin reuptake inhibitor, in the prevention of relapse of generalized social phobia. Fifty adult outpatients with generalized social phobia who were rated much or very much improved on the Clinical Global Impression Scale of Improvement (CGI-I) after 20 weeks of sertraline treatment (50-200 mg/day) were randomly …
Authors
Walker JR; Van Ameringen MA; Swinson R; Bowen RC; Chokka PR; Goldner E; Johnston DC; Lavallie Y-J; Nandy S; Pecknold JC
Journal
Journal of Clinical Psychopharmacology, Vol. 20, No. 6, pp. 636–644
Publisher
Wolters Kluwer
Publication Date
December 2000
DOI
10.1097/00004714-200012000-00009
ISSN
0271-0749